Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide.

Literature DB >> 12037096

Comparison of the ESP and BACTEC systems for testing susceptibilities of Mycobacterium tuberculosis complex isolates to pyrazinamide.

Abstract

Fifty isolates of Mycobacterium tuberculosis complex were tested for susceptibility to pyrazinamide (PZA) by the ESP (Trek Diagnostic Systems, Westlake, Ohio) and BACTEC (BD Biosciences, Sparks, Md.) test systems. Initial results showed concordance for 48 of the isolates. On retest, the two discordant isolates were resolved in favor of the ESP system. The ESP Myco susceptibility test system generates rapid, reliable PZA test results.

Entities: Chemical Species

Mesh：

Substances：

Year: 2002 PMID： 12037096 PMCID： PMC130663 DOI： 10.1128/JCM.40.6.2238-2239.2002

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

6 in total

1. Use of nucleic acid probes to identify mycobacteria directly from Difco ESP-Myco bottles.

Authors: V J Labombardi; L Carter; S Massarella
Journal: J Clin Microbiol Date: 1997-04 Impact factor: 5.948

2. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Authors: M M Hannan; E P Desmond; G P Morlock; G H Mazurek; J T Crawford
Journal: J Clin Microbiol Date: 2001-02 Impact factor: 5.948

3. New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Authors: L Heifets; T Sanchez
Journal: J Clin Microbiol Date: 2000-04 Impact factor: 5.948

4. The resurgence of tuberculosis: is your laboratory ready?

Authors: F C Tenover; J T Crawford; R E Huebner; L J Geiter; C R Horsburgh; R C Good
Journal: J Clin Microbiol Date: 1993-04 Impact factor: 5.948

5. Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test.

Authors: M A Miller; L Thibert; F Desjardins; S H Siddiqi; A Dascal
Journal: J Clin Microbiol Date: 1996-01 Impact factor: 5.948

6. Control of tuberculosis in the United States. American Thoracic Society.

Authors:
Journal: Am Rev Respir Dis Date: 1992-12

6 in total

7 in total

1. Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.

Authors: M Espasa; M Salvadó; E Vicente; G Tudó; F Alcaide; P Coll; N Martin-Casabona; M Torra; D Fontanals; J González-Martín
Journal: J Clin Microbiol Date: 2011-11-30 Impact factor: 5.948

Review 2. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.

Authors: Claudio Piersimoni; Armando Olivieri; Luca Benacchio; Claudio Scarparo
Journal: J Clin Microbiol Date: 2006-01 Impact factor: 5.948

3. Simple fibroblast-based assay to test the pyrazinamide susceptibility of Mycobacterium tuberculosis.

Authors: Takemasa Takii; Sonomi Hamasaki; Kazue Hirano; Chiyoji Abe; Kikuo Onozaki
Journal: Antimicrob Agents Chemother Date: 2005-02 Impact factor: 5.191

4. Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.

Authors: Pushpendra Singh; Clement Wesley; G P S Jadaun; Sunil Kumar Malonia; R Das; P Upadhyay; J Faujdar; P Sharma; P Gupta; Abhay Kumar Mishra; Kalpana Singh; D S Chauhan; V D Sharma; U D Gupta; K Venkatesan; V M Katoch
Journal: J Clin Microbiol Date: 2006-11-08 Impact factor: 5.948